Jacob Smith3 Apr 2026U.S. President Donald Trump has unveiled sweeping tariff changes, proposing duties of up to 100% on pharmaceutical imports unless companies reduce prices and shift manufacturing to the United States. The policy includes a 120–180 day compliance window and selective relief for allies, reflecting Washington’s push for domestic production amid rising global tensions linked to the Iran conflict. #Dona4 likes4 comments#breakingnews#uspolicy#economy#pharma#globaltrade
